EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comprehensive Mechanistic View of the Hydrolysis of Oxadiazole-Based Inhibitors by Histone Deacetylase 6 (HDAC6)

Lucia Motlová, Ivan Šnajdr iD, Zsófia Kutil iD, Erik Andris iD, Jakub Ptáček, Adéla Novotná iD, Zora Nováková iD, Barbora Havlínová, Werner Tueckmantel, Helena Dráberová, Pavel Majer, Mike Schutkowski iD und 3 weitere

ACS Chemical Biology · 2023

DOI: 10.1021/acschembio.3c00212 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Biology, 2023. Verfasst von Lucia Motlová und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Prumyslova 595, 252 50 Vestec, Czech Republic. Hauptthemen laut MEDLINE: Oxadiazoles, Histone Deacetylase Inhibitors. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerstvo ?kolstv?, Ml?de?e a Telov?chovy, Grantov? Agentura Cesk? Republiky, Akademie Ved Cesk? Republiky.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Histone deacetylase (HDAC) inhibitors used in the clinic typically contain a hydroxamate zinc-binding group (ZBG). However, more recent work has shown that the use of alternative ZBGs, and, in particular, the heterocyclic oxadiazoles, can confer higher isoenzyme selectivity and more favorable ADMET profiles. Herein, we report on the synthesis and biochemical, crystallographic, and computational characterization of a series of oxadiazole-based inhibitors selectively targeting the HDAC6 isoform. Surprisingly, but in line with a very recent finding reported in the literature, a crystal structure of the HDAC6/inhibitor complex revealed that hydrolysis of the oxadiazole ring transforms the parent oxadiazole into an acylhydrazide through a sequence of two hydrolytic steps. An identical cleavage pattern was also observed both in vitro using the purified HDAC6 enzyme as well as in cellular systems. By employing advanced quantum and molecular mechanics (QM/MM) and QM calculations, we elucidated the mechanistic details of the two hydrolytic steps to obtain a comprehensive mechanistic view of the double hydrolysis of the oxadiazole ring. This was achieved by fully characterizing the reaction coordinate, including identification of the structures of all intermediates and transition states, together with calculations of their respective activation (free) energies. In addition, we ruled out several (intuitively) competing pathways. The computed data (ΔG‡ ≈ 21 kcal·mol-1 for the rate-determining step of the overall dual hydrolysis) are in very good agreement with the experimentally determined rate constants, which a posteriori supports the proposed reaction mechanism. We also clearly (and quantitatively) explain the role of the -CF3 or -CHF2 substituent on the oxadiazole ring, which is a prerequisite for hydrolysis to occur. Overall, our data provide compelling evidence that the oxadiazole warheads can be efficiently transformed within the active sites of target metallohydrolases to afford reaction products possessing distinct selectivity and inhibition profiles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxadiazolesHistone Deacetylase InhibitorsHistone Deacetylase 6HydrolysisHydroxamic Acids

Substanzen

Histone Deacetylase 6OxadiazolesHistone Deacetylase InhibitorsHydroxamic Acids

Autor:innen und Institutionen

  • Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Prumyslova 595, 252 50 Vestec, Czech Republic.
  • Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo náměstí 2, 166 10 Prague 6, Czech Republic.
  • StarWise Therapeutics LLC, University Research Park, Inc., Madison, Wisconsin 53719, United States.
  • Department of Enzymology, Charles Tanford Protein Center, Institute of Biochemistry and Biotechnology, Martin-Luther-University Halle-Wittenberg, 06120 Halle, Germany.

ORCID-Profile: Ivan Šnajdr, Zsófia Kutil, Erik Andris, Adéla Novotná, Zora Nováková, Mike Schutkowski, Lubomír Rulíšek, Cyril Bařinka

Förderung

  • Ministerstvo ?kolstv?, Ml?de?e a Telov?chovy
  • Grantov? Agentura Cesk? Republiky
  • Akademie Ved Cesk? Republiky

Zitieren

APA

Motlová, L., Šnajdr, I., Kutil, Z., Andris, E., Ptáček, J., Novotná, A., Nováková, Z., Havlínová, B., Tueckmantel, W., Dráberová, H., Majer, P., Schutkowski, M., Kozikowski, A., Rulíšek, L., & Bařinka, C. (2023). Comprehensive Mechanistic View of the Hydrolysis of Oxadiazole-Based Inhibitors by Histone Deacetylase 6 (HDAC6). ACS Chemical Biology. https://doi.org/10.1021/acschembio.3c00212

Vancouver

Motlová L, Šnajdr I, Kutil Z, Andris E, Ptáček J, Novotná A, et al. Comprehensive Mechanistic View of the Hydrolysis of Oxadiazole-Based Inhibitors by Histone Deacetylase 6 (HDAC6). ACS Chemical Biology. 2023. doi:10.1021/acschembio.3c00212

BibTeX
@article{Motlov2023,
  author = {Motlová, Lucia and Šnajdr, Ivan and Kutil, Zsófia and Andris, Erik and Ptáček, Jakub and Novotná, Adéla and Nováková, Zora and Havlínová, Barbora and Tueckmantel, Werner and Dráberová, Helena and Majer, Pavel and Schutkowski, Mike and Kozikowski, Alan and Rulíšek, Lubomír and Bařinka, Cyril},
  title = {Comprehensive Mechanistic View of the Hydrolysis of Oxadiazole-Based Inhibitors by Histone Deacetylase 6 (HDAC6)},
  journal = {ACS Chemical Biology},
  year = {2023},
  doi = {10.1021/acschembio.3c00212}
}
Kostenlos starten →